2020
DOI: 10.1016/j.jval.2020.08.153
|View full text |Cite
|
Sign up to set email alerts
|

PCN16 External Control Analysis of Overall Survival in BRAFV600 Mutated Metastatic NSCLC: Comparing Single-Arm Dabrafenib+Trametinib Clinical Trial Outcomes with Real-World Standards of Care

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles